Vco from 135 ± 9 to 153 ± 11 mi/minI2 (P < 0.05), PaCO2 from 36 ± 2 to 47 ± 2 mm Hg (P < 0.001), CI from 3.0 ± 0.2 to 3.5 ± 0.9 (P < 0.01 ), VD/VT from 32 ± 1 to 37 ± 1 (P < 0.05), and rate of respiration per minute from 13 ± 1 to 18 ± 1 (P < 0.01).
During IMV, Vo2 increased from 157 ± 17 to [94 ± 15 ml/min/m2 (P < 0.01), Vcos from 134 ± 11 to 177 ± 10 nd/minIm2 (P < 0.01 ), PaCO2 from 38 ± 3 to 50 ± 2 mm Hg (P < 0.001 ), right atrial pressure from 8 ± 1 to 10 ± 1 (P < 0.05), and CI from 3.4 ± 0.2 to 3.9 ± 0.2 (P < 0.05). There were no changes in VD/VT.
Decreases
were observed in S'c o2 from 72 ± 3 to 67 ± 2 percent (P < 0.05) and pHa 7.35 ± 0.01 to 7.29 ± 0.01 (P < 0.001) during a trial of IMV. 
